dactinomycin has been researched along with Bacterial Pneumonia in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujii, R; Fujiwara, T; Inui, T; Ishihara, T; Itoh, M; Iwai, N; Kamiya, H; Kawaoi, Y; Kawasaki, H; Kondoh, Y; Kuno, K; Meguro, H; Miyajima, Y; Nakamura, H; Nakayama, M; Niinou, K; Sakurai, M; Sato, Y; Suga, S; Sunakawa, K; Taniguchi, K; Terashima, I; Toyonaga, Y; Yokota, T; Yoshimura, K | 1 |
Asano, Y; Iriyama, J; Ishigo, S; Minakuchi, K | 1 |
Aoki, K; Asano, S; Bessho, M; Fujita, A; Furusawa, S; Higashihara, M; Hirai, H; Hoshino, S; Hotta, T; Kitamura, K; Koike, M; Kuraishi, Y; Kurihara, I; Mizoguchi, H; Nagoshi, H; Nishimura, M; Nonaka, Y; Ohbayashi, Y; Omine, M; Oshimi, K; Ozawa, K; Suzuki, K; Takaku, F; Togawa, A; Urabe, A; Wakabayashi, Y | 1 |
Higashiyama, Y; Hirakata, Y; Kadota, JI; Kakeya, H; Kaneko, Y; Kohno, S; Kuroki, M; Miyazaki, Y; Ohi, H; Tomono, K; Yanagihara, K | 1 |
2 trial(s) available for dactinomycin and Bacterial Pneumonia
Article | Year |
---|---|
[Optimum dose study of cefozopran in the pediatric field].
Topics: Bacterial Infections; Cefozopran; Cephalosporins; Child; Child, Preschool; Female; Humans; Infant; Male; Pneumonia, Bacterial | 1996 |
[Efficacy and safety of cefozopran (CZOP) monotherapy and combination therapy with CZOP and amikacin (AMK) for infections accompanying hematological diseases].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cefozopran; Cephalosporins; Drug Therapy, Combination; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Male; Middle Aged; Pneumonia, Bacterial; Sepsis | 2000 |
2 other study(ies) available for dactinomycin and Bacterial Pneumonia
Article | Year |
---|---|
[Bacteriological and clinical break points: evaluation of the usefulness of cefozopran based on MIC].
Topics: Cefozopran; Cephalosporins; Citrobacter; Enterobacter; Enterococcus; Escherichia coli; Humans; Klebsiella; Methicillin Resistance; Microbial Sensitivity Tests; Pneumonia, Bacterial; Pseudomonas aeruginosa; Serratia; Staphylococcus aureus | 1999 |
Effects of parenterally administered ciprofloxacin in a murine model of pulmonary Pseudomonas aeruginosa infection mimicking ventilator-associated pneumonia.
Topics: Animals; Anti-Infective Agents; Area Under Curve; Cefozopran; Cephalosporins; Cilastatin; Ciprofloxacin; Disease Models, Animal; Imipenem; Infusions, Parenteral; Male; Mice; Pneumonia, Bacterial; Protease Inhibitors; Pseudomonas aeruginosa; Pseudomonas Infections; Respiration, Artificial; Thienamycins | 2001 |